Company: AEMD
Filing Date: 2025-02-12
Form Type: 10-Q
Source: 0001683168-25-000960
Chunk: 20

Company: AETHLON MEDICAL INC
Filing Date: 2025-02-12
Form: 10-Q
Item: Item 1
Chunk 20
---
 31, 2024 and 2023.

Stock options outstanding that have vested as
of December 31, 2024 and stock options that are expected to vest subsequent to December 31, 2024 are as follows:

    Schedule of stock options outstanding 

    Number of Shares  
    Weighted Average Exercise Price  
    Weighted Average Remaining Contractual Term in Years 
  
    Vested 
     62,007  
    $17.91  
     4.47 
  
    Expected to vest 
     7,893  
    $14.45  
     7.08 
  
    Total 
     69,900  

A summary of stock option activity during the
nine months ended December 31, 2024 is presented below:

    Schedule of stock option activity 

    Amount  
    Range of Exercise Price  
    Weighted Average  Exercise Price 
  
    Outstanding at beginning of year 
     86,466  
    $6.90 – 25.20  
    $22.40 
  
    Granted 
     –  
    $–  
    $– 
  
    Cancelled/Expired 
     16,566  
    $6.90-1,425.00  
    $17.32 
  
    Outstanding December 31, 2024 
     69,900  
    $12.80 – 25.20  
    $17.52 
  
    Exercisable, December 31, 2024 
     62,007  
    $12.80 – 25.20  
    $17.91 

There were no stock option grants during the three
months ended December 31, 2024 and 2023. There were no RSUs granted during the three months December 31, 2024 and 2023. There were no
stock option exercises during the three months ended December 31, 2024 and 2023. On December 31, 2024, our outstanding stock options had
no intrinsic value, since the closing share price on that date of $0.86 per share was below the exercise price of our outstanding stock
options.

The table below summarizes nonvested stock options as of December 31,
2024 and changes during the three months ended December 31, 2024.

    Schedule of non vested stock options 

    Shares